Letters were sent about ranibizumab and Emerade adrenaline auto-injectors.Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg.The Commission on Human Medicines has issued a series of recommendations to strengthen measures to minimise risk with the yellow fever vaccine (Stamaril) following very rare fatal reactions.Establish hepatitis B status before initiating carfilzomib and in patients with unknown hepatitis B virus serology who are already being treated with carfilzomib. It will take only 2 minutes to fill in. Patients on nivolumab who present with diarrhoea or other symptoms of colitis, and those who do not respond to steroid treatment for immune-related colitis, should be investigated to exclude other causes, including infection…For most patients and most medicines, estimated Glomerular Filtration Rate (eGFR) is an appropriate measure of renal function for determining dosage adjustments in renal impairment; however, in some circumstances, the Cockcr…Healthcare professionals should be aware of alerts and letters issued about adrenaline auto-injectors in September and October 2019.Don’t include personal or financial information like your National Insurance number or credit card details.To help us improve GOV.UK, we’d like to know more about your visit today. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Find drug safety updates issued by MHRA. It is given by mouth or by injection into a vein. A prescription ACE inhibitor used to treat high blood pressure and heart failure is being recalled. Enalapril, sold under the brand name Vasotec among others, is a medication used to treat high blood pressure, diabetic kidney disease, and heart failure. Date modified: 2020-09-12 This would include AEDs such as 8/20/18-The FDA approved Diacomit (stiripentol) for the treatment of seizures associated with Dravet syndrome in persons 2 years of age and older. A summary of letters and drug alerts recently sent to healthcare professionals.Key MHRA advice and guidance issued so far on medicines safety and pharmacovigilance, including on reporting to the Yellow Card Scheme. Most ACE inhibitors end in the suffix "pril," such as enalapril, fosinopril, lisinopril and ramipril. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation. Start studying PTCB Practice Exam #6. Don’t worry we won’t send you spam or share your email address with anyone. A summary of letters and drug alerts recently sent to healthcare professionals, including recommendations to reduce handling errors with leuprorelin-containing depot medicines.A summary of Medical Device Alerts recently issued by the MHRA.We have introduced pack size restrictions, revised recommended ages for use, and new safety warnings for over-the-counter stimulant laxatives (orally and rectally administered) following a national safety review.Before initiating systemic vascular endothelial growth factor (VEGF) pathway inhibitors, carefully consider the risk of aneurysm and artery dissection in patients with risk factors.Make a clear distinction between liposomal, pegylated-liposomal, lipid-complex and conventional formulations when prescribing, dispensing, administering, and communicating about these medicines.A summary of letters and drug alerts recently sent to healthcare professionals. The list includes certain antibiotics, birth control pills, diuretics, antihistamines, antidepressants and many retinoids (such as Vitamin A acid). Risk of meningioma with cyproterone acetate increases with increasing cumulative dose.Remain vigilant for signs and symptoms of bleeding complications during treatment with DOACs (apixaban, dabigatran, edoxaban, rivaroxaban), especially in patients with increased bleeding risks.A summary of letters and drug alerts recently sent to healthcare professionals.